Blog

China’s Diabetes Epidemic Keeps Demand for Insulin High

China’s economic success over the last three decades has brought the country’s 1.4 billion people unprecedented prosperity. However, success has come at great cost. Due to changes in diet, transition to less physically demanding jobs, excessive smoking and…


CPhI China to Include Tour of PaizaBio’s Hangzhou CMO Facility

Participants in CPhI China 2016 June 21-23 at the Shanghai New International Expo Centre have been given a special opportunity – a tour of PaizaBio’s CGMP-qualified, aseptic fill-and-finish facilities in Hangzhou. The facility is owned by Ausia BioTech,…


PaizaBio’s Deere Joins China’s Dr. Xu Ming in Live Webcast on CFDA’s New Policies

In advance of CPhI China, Pharmaceutical Technology is hosting two days of live webcasts to create clarity on China’s new policies on drug innovation and commercialization. Hosted by Rita Peters, the webcasts bring two experts to the forefront…


Moody’s, China, Drugs, and Yogi Berra

Last week, the illustrious Wall Street rating agency Moody’s reported on two interesting outlook downgrades, China as a country and pharmaceuticals as a global industrial sector. Now I won’t hold Moody’s alleged role in rating many of the…


Deere to Give Chinese Drug Execs Western Take on cFDA’s New Policies

In an interesting turn of events, Chinese and Southeast Asia drug executives are turning to an American to “read the tea leaves” on the cFDA’s sweeping policy changes regarding drug innovation and commercialization. Announced in late 2015, these…


China’s only sterile university welcomes students March 23-25

In just six weeks, the Trans-Pacific Aseptic Institute of Training® (TPA-IT) will welcome its first class of students on the campus of Ausia BioTech in Hangzhou, China. The inaugural session of TPA-IT is set for March 23-25, 2016….


China’s New Year: The Year of the Monkey King?

  One of the great classics of Chinese literature is the story of the Monkey King, or The Journey West, as it is known to the Chinese. It is an allegorical tale about an independently rebellious, very brave,…


Bullish on Contract Manufacturing of Sterile Injectables in China

China’s financial markets are off to a rocky start in 2016, causing analysts to worry about the health of the world’s second largest economy and the potential negative knock-on effect that a protracted slowdown could have on emerging…


China’s Drug Policy Changes: What They Mean for Western Pharma

In a radio broadcast in 1939 Winston Churchill described Russia: ““I cannot forecast to you the action of Russia. It is a riddle, wrapped in a mystery, inside an enigma; but perhaps there is a key. That key…


Hey Western Pharma, Scrambling for Real Growth? Revisit the China Opportunity

Mergers and acquisitions, operational rationalization and stock repurchasing will only sustain a company’s bottom line for so long. At some point, healthcare spending levels, even in the United States, will negatively impact price and reimbursement, thus reinstating unit…